DIM (3,3'-diindolylmethane)

Views 1262
Download the GMI DOC on this Topic

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
5 Diseases Researched for DIM (3,3'-diindolylmethane)
NameACCKFocus
Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios110Locked
Breast Cancer23Locked
Breast Cancer: Lung Metastasis12Locked
Pancreatic Cancer11Locked
Prostate Cancer11Locked
2 Pharmacological Actions Researched for DIM (3,3'-diindolylmethane)
NameACCKFocus
Anti-metastatic12Locked
Chemosensitizer11Locked
Related Topics

DIM (3,3'-diindolylmethane) is a Sub of the following Topic

View the Evidence:
5 Abstracts with DIM (3,3'-diindolylmethane) Research

[+]

DIM improves the estrogen profile in postmenopausal women with a history of early-stage breast cancer. Jan 01, 2004

Pubmed Data : Nutr Cancer. 2004;50(2):161-7. PMID: 15623462
Article Published Date : Jan 01, 2004
Study Type : Human Study
Additional Links
Substances : DIM (3,3'-diindolylmethane)
Diseases : Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios
[+]

DIM inhibits lung metastasis of mammary cancer cells in mice. Oct 28, 2009

Pubmed Data : J Nutr. 2009 Oct 28. PMID: 19864400
Article Published Date : Oct 28, 2009
Study Type : Animal Study
Additional Links
Substances : DIM (3,3'-diindolylmethane)
Diseases : Breast Cancer, Breast Cancer: Lung Metastasis
Pharmacological Actions : Anti-metastatic
[+]

DIM (3,3'-diindolylmethane) sensitizes breast tumors to chemotherapy. Oct 01, 2007

Pubmed Data : Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3. PMID: 17913854
Article Published Date : Oct 01, 2007
Study Type : In Vitro Study
Additional Links
Substances : DIM (3,3'-diindolylmethane)
Diseases : Breast Cancer
Pharmacological Actions : Chemosensitizer
Additional Keywords : Drug-Plant-Vitamin Synergies
[+]

DIM inhibits prostate cancer cell growth. May 01, 2000

Pubmed Data : Carcinogenesis. 2000 May;21(5):921-7. PMID: 17047070
Article Published Date : May 01, 2000
Study Type : In Vitro Study
Additional Links
Substances : DIM (3,3'-diindolylmethane)
Diseases : Prostate Cancer
[+]

The chemotherapeutic activity of erlotinib is potentiated by 3,3' diindolymethane (DIM) against pancreatic cancer, in vitro and in vivo. Jun 01, 2008

Pubmed Data : Mol Cancer Ther. 2008 Jun;7(6):1708-19. PMID: 18566242
Article Published Date : Jun 01, 2008
Study Type : In Vitro Study
Additional Links
Substances : DIM (3,3'-diindolylmethane)
Diseases : Pancreatic Cancer
Additional Keywords : Chemotherapeutic Synergy: Erlotinib, Drug-Plant-Vitamin Synergies

Copyright: lightwise / 123RF Stock Photo

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Connect with GreenMedInfo